{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T14:38:25Z","timestamp":1766241505034,"version":"3.48.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,20]]},"DOI":"10.7759\/cureus.99699","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T14:34:40Z","timestamp":1766241280000},"source":"Crossref","is-referenced-by-count":0,"title":["Preoperative Risk Stratification of Adnexal Masses Using the International Ovarian Tumor Analysis (IOTA) Simple Rules and Risk of Malignancy Index (RMI) 2: A Prospective Diagnostic Study From a Tertiary Centre in Southern India"],"prefix":"10.7759","author":[{"given":"Kaarthika","family":"T","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasikala","family":"Kathiresan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcpo.2025.100582","article-title":"Challenges and opportunities in ovarian cancer care: a qualitative study of clinician perspectives from 24 low- and middle-income countries","volume":"44","author":"Bajwa A","year":"2025","unstructured":"Bajwa A, Chidebe RC, Adams T, et al.. Challenges and opportunities in ovarian cancer care: a qualitative study of clinician perspectives from 24 low- and middle-income countries. J Cancer Policy. 2025, 44:100582. 10.1016\/j.jcpo.2025.100582","journal-title":"J Cancer Policy"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-022-12151-6","article-title":"GLOBOCAN 2020 report on global cancer burden: challenges and opportunities for surgical oncologists","volume":"29","author":"Deo SV","year":"2022","unstructured":"Deo SV, Sharma J, Kumar S. GLOBOCAN 2020 report on global cancer burden: challenges and opportunities for surgical oncologists. Ann Surg Oncol. 2022, 29:6497-500. 10.1245\/s10434-022-12151-6","journal-title":"Ann Surg Oncol"},{"key":"ref3","article-title":"Ovarian cancers: evolving paradigms in research and care","year":"2016","unstructured":"Ovarian Cancers. Evolving Paradigms in Research and Care. National Academies Press (US), Washington, DC; 2016. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK367618\/."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.61","article-title":"Ovarian cancer","volume":"2","author":"Matulonis UA","year":"2016","unstructured":"Matulonis UA, Sood AK, Fallowfield L, Howitt BE, Sehouli J, Karlan BY. Ovarian cancer. Nat Rev Dis Primers. 2016, 2:16061. 10.1038\/nrdp.2016.61","journal-title":"Nat Rev Dis Primers"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-025-01707-1","article-title":"Accurate prediction of benign and malignant adnexal tumors in surgical resection and conservative treatment: construction and external validation of a diagnostic model based on CEUS, HE4, and O-RADS US v2022 evaluation","volume":"18","author":"Liu C","year":"2025","unstructured":"Liu C, Zhu Y, Dai K, et al.. Accurate prediction of benign and malignant adnexal tumors in surgical resection and conservative treatment: construction and external validation of a diagnostic model based on CEUS, HE4, and O-RADS US v2022 evaluation. J Ovarian Res. 2025, 18:123. 10.1186\/s13048-025-01707-1","journal-title":"J Ovarian Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14133210","article-title":"Defining models to classify between benign and malignant adnexal masses using routine laboratory parameters","volume":"14","author":"Reiser E","year":"2022","unstructured":"Reiser E, Pils D, Grimm C, Hoffmann I, Polterauer S, Kranawetter M, Aust S. Defining models to classify between benign and malignant adnexal masses using routine laboratory parameters. Cancers (Basel). 2022, 14:3210. 10.3390\/cancers14133210","journal-title":"Cancers (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31821c62b6","article-title":"Management of the adnexal mass","volume":"117","author":"Liu JH","year":"2011","unstructured":"Liu JH, Zanotti KM. Management of the adnexal mass. Obstet Gynecol. 2011, 117:1413-28. 10.1097\/AOG.0b013e31821c62b6","journal-title":"Obstet Gynecol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1990.tb02448.x","article-title":"A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer","volume":"97","author":"Jacobs I","year":"1990","unstructured":"Jacobs I, Oram D, Fairbanks J, Turner J, Frost C, Grudzinskas JG. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol. 1990, 97:922-9. 10.1111\/j.1471-0528.1990.tb02448.x","journal-title":"Br J Obstet Gynaecol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56120702","article-title":"Early-stage ovarian malignancy score versus risk of malignancy indices: accuracy and clinical utility for preoperative diagnosis of women with adnexal masses","volume":"56","author":"Phinyo P","year":"2020","unstructured":"Phinyo P, Patumanond J, Saenrungmuaeng P, et al.. Early-stage ovarian malignancy score versus risk of malignancy indices: accuracy and clinical utility for preoperative diagnosis of women with adnexal masses. Medicina (Kaunas). 2020, 56:702. 10.3390\/medicina56120702","journal-title":"Medicina (Kaunas)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.19082\/1505","article-title":"Diagnostic value of the risk of malignancy index (RMI) for detection of pelvic malignancies compared with pathology","volume":"7","author":"Karimi-Zarchi M","year":"2015","unstructured":"Karimi-Zarchi M, Mojaver SP, Rouhi M, Hekmatimoghaddam SH, Moghaddam RN, Yazdian-Anari P, Teimoori S. Diagnostic value of the risk of malignancy index (RMI) for detection of pelvic malignancies compared with pathology. Electron Physician. 2015, 7:1505-10. 10.19082\/1505","journal-title":"Electron Physician"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1996.tb09882.x","article-title":"Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses","volume":"103","author":"Tingulstad S","year":"1996","unstructured":"Tingulstad S, Hagen B, Skjeldestad FE, Onsrud M, Kiserud T, Halvorsen T, Nustad K. Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses. Br J Obstet Gynaecol. 1996, 103:826-31. 10.1111\/j.1471-0528.1996.tb09882.x","journal-title":"Br J Obstet Gynaecol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s13224-014-0609-1","article-title":"Risk of malignancy index (RMI) in evaluation of adnexal mass","volume":"65","author":"Javdekar R","year":"2015","unstructured":"Javdekar R, Maitra N. Risk of malignancy index (RMI) in evaluation of adnexal mass. J Obstet Gynaecol India. 2015, 65:117-21. 10.1007\/s13224-014-0609-1","journal-title":"J Obstet Gynaecol India"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.31194","article-title":"The International Ovarian Tumor Analysis-Assessment of Different Neoplasias in the Adnexa (IOTA-ADNEX) model assessment for risk of ovarian malignancy in adnexal masses","volume":"14","author":"Cherukuri S","year":"2022","unstructured":"Cherukuri S, Jajoo S, Dewani D. The International Ovarian Tumor Analysis-Assessment of Different Neoplasias in the Adnexa (IOTA-ADNEX) model assessment for risk of ovarian malignancy in adnexal masses. Cureus. 2022, 14:e31194. 10.7759\/cureus.31194","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2014.15.13.5123","article-title":"IOTA simple rules in differentiating between benign and malignant ovarian tumors","volume":"15","author":"Tantipalakorn C","year":"2014","unstructured":"Tantipalakorn C, Wanapirak C, Khunamornpong S, Sukpan K, Tongsong T. IOTA simple rules in differentiating between benign and malignant ovarian tumors. Asian Pac J Cancer Prev. 2014, 15:5123-6. 10.7314\/apjcp.2014.15.13.5123","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref15","article-title":"Comparison of International Ovarian Tumour Analysis (IOTA) adnex model with IOTA Simple Rules and Risk of Malignancy Index (RMI) for preoperative prediction of benign and malignant adnexal masses","volume":"14","author":"Abinaya C","year":"2025","unstructured":"Abinaya C, Sunil Kumar Samal, Setu Rathod, Dheepikaa, Sarala, Shreya Mishra, Priyanka. Comparison of International Ovarian Tumour Analysis (IOTA) adnex model with IOTA Simple Rules and Risk of Malignancy Index (RMI) for preoperative prediction of benign and malignant adnexal masses. Frontiers in Health Informatics. 2025, 14:69-74.","journal-title":"Frontiers in Health Informatics"},{"key":"ref16","unstructured":"STARD 2015. an updated list of essential items for reporting diagnostic accuracy studies. (2025). Accessed: 2025: https:\/\/www.equator-network.org\/reporting-guidelines\/stard\/."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.15562\/bmj.v10i2.2591","article-title":"The comparison of diagnostic accuracy of risk of Malignancy index to IOTA simple rules in diagnosing adnexal masses","volume":"10","author":"Mongan SP","year":"2021","unstructured":"Mongan SP, Sutandar Y, Laihad BJ. The comparison of diagnostic accuracy of risk of Malignancy index to IOTA simple rules in diagnosing adnexal masses. Bali Med J. 2021, 10:783-876. 10.15562\/bmj.v10i2.2591","journal-title":"Bali Med J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/jmh.JMH_103_20","article-title":"Predicting malignancy in adnexal masses by the International Ovarian Tumor Analysis-Simple Rules","volume":"11","author":"Solanki V","year":"2020","unstructured":"Solanki V, Singh P, Sharma C, et al.. Predicting malignancy in adnexal masses by the International Ovarian Tumor Analysis-Simple Rules. J Midlife Health. 2020, 11:217-23. 10.4103\/jmh.JMH_103_20","journal-title":"J Midlife Health"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.51253\/pafmj.v75iSUPPL-4.6771","article-title":"Comparison of RMI (Risk Malignancy Index) and Simple Rules risk model in evaluation of adnexal masses taking histopathology as gold standard","volume":"75","author":"Choudhry A","year":"2025","unstructured":"Choudhry A, Shahwar D, Tahir Z, Tahir I, Arif S. Comparison of RMI (Risk Malignancy Index) and Simple Rules risk model in evaluation of adnexal masses taking histopathology as gold standard. Pak Armed Force Med J. 2025, 75:S520. 10.51253\/pafmj.v75iSUPPL-4.6771","journal-title":"Pak Armed Force Med J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2025.114585","article-title":"Beyond the image: performance of O-RADS, ADNEX, IOTA simple rules & RMI 4 in differentiating benign and malignant adnexal masses-an Indian perspective","volume":"313","author":"Khastgir G","year":"2025","unstructured":"Khastgir G, Siwatch S, Singh T, Jain V, Sikka P, Srinivasan R. Beyond the image: performance of O-RADS, ADNEX, IOTA simple rules & RMI 4 in differentiating benign and malignant adnexal masses-an Indian perspective. Eur J Obstet Gynecol Reprod Biol. 2025, 313:114585. 10.1016\/j.ejogrb.2025.114585","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.12891","article-title":"Comparison of the diagnostic accuracy of International Ovarian Tumor Analysis simple rules and the risk of malignancy index to discriminate between benign and malignant adnexal masses","volume":"146","author":"Auekitrungrueng R","year":"2019","unstructured":"Auekitrungrueng R, Tinnangwattana D, Tantipalakorn C, Charoenratana C, Lerthiranwong T, Wanapirak C, Tongsong T. Comparison of the diagnostic accuracy of International Ovarian Tumor Analysis simple rules and the risk of malignancy index to discriminate between benign and malignant adnexal masses. Int J Gynaecol Obstet. 2019, 146:364-9. 10.1002\/ijgo.12891","journal-title":"Int J Gynaecol Obstet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/434238-preoperative-risk-stratification-of-adnexal-masses-using-the-international-ovarian-tumor-analysis-iota-simple-rules-and-risk-of-malignancy-index-rmi-2-a-prospective-diagnostic-study-from-a-tertiary-centre-in-southern-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T14:34:42Z","timestamp":1766241282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/434238-preoperative-risk-stratification-of-adnexal-masses-using-the-international-ovarian-tumor-analysis-iota-simple-rules-and-risk-of-malignancy-index-rmi-2-a-prospective-diagnostic-study-from-a-tertiary-centre-in-southern-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.99699","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,20]]}}}